LivaNova PLC Increase (Decrease) in Inventories
LivaNova PLC (LIVN) reported Increase (Decrease) in Inventories of $10.14 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInInventories · last filed 2026-08-05
- LivaNova PLC increase (decrease) in inventories for the quarter ending 2026-06-30 was $8.60M, a 142.64% increase year-over-year.
- LivaNova PLC increase (decrease) in inventories for the quarter ending 2026-03-31 was $1.55M, a 38.01% decline year-over-year.
- LivaNova PLC increase (decrease) in inventories for the quarter ending 2025-12-31 was -$2.81M.
- LivaNova PLC increase (decrease) in inventories for the quarter ending 2025-09-30 was $2.06M, a 30.27% decline year-over-year.
- LivaNova PLC increase (decrease) in inventories for fiscal 2025 was $5.29M, a 21.70% decline from fiscal 2024.
- LivaNova PLC increase (decrease) in inventories for fiscal 2024 was $6.76M, a 76.27% decline from fiscal 2023.
- LivaNova PLC increase (decrease) in inventories for fiscal 2023 was $28.48M, a 10.90% increase from fiscal 2022.
- LivaNova PLC increase (decrease) in inventories for fiscal 2022 was $25.68M.
| Period end | Increase (Decrease) in Inventories 3 month | Increase (Decrease) in Inventories 3 month as first filed | Increase (Decrease) in Inventories 6 month | Increase (Decrease) in Inventories 6 month as first filed | Increase (Decrease) in Inventories 8 month | Increase (Decrease) in Inventories 9 month | Increase (Decrease) in Inventories 9 month as first filed | Increase (Decrease) in Inventories 12 month | Increase (Decrease) in Inventories 12 month as first filed | Increase (Decrease) in Inventories 20 month |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $8.60M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $10.14M 10-Q · filed 2026-08-05 | $7.34M derived: sum of 3 quarters · filed 2026-08-05 | $9.40M derived: sum of 4 quarters · filed 2026-08-05 | ||||||
| 2026-03-31 | $1.55M 10-Q · filed 2026-05-06 | -$1.26M derived: sum of 2 quarters · filed 2026-05-06 | $799.00K derived: sum of 3 quarters · filed 2026-05-06 | $4.34M derived: sum of 4 quarters · filed 2026-08-05 | ||||||
| 2025-12-31 | -$2.81M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | -$747.00K derived: sum of 2 quarters · filed 2026-02-25 | $2.80M derived: sum of 3 quarters · filed 2026-08-05 | $5.29M 10-K · filed 2026-02-25 | ||||||
| 2025-09-30 | $2.06M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $5.61M derived: sum of 2 quarters · filed 2026-08-05 | $8.10M 10-Q · filed 2025-11-05 | $962.00K derived: sum of 4 quarters · filed 2026-08-05 | ||||||
| 2025-06-30 | $3.54M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $6.04M 10-Q · filed 2026-08-05 | -$1.10M derived: sum of 3 quarters · filed 2026-08-05 | $1.86M derived: sum of 4 quarters · filed 2026-08-05 | ||||||
| 2025-03-31 | $2.49M 10-Q · filed 2026-05-06 | -$4.64M derived: sum of 2 quarters · filed 2026-05-06 | -$1.69M derived: sum of 3 quarters · filed 2026-05-06 | $1.10M derived: sum of 4 quarters · filed 2026-05-06 | ||||||
| 2024-12-31 | -$7.14M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | -$4.18M derived: sum of 2 quarters · filed 2026-02-25 | -$1.39M derived: sum of 3 quarters · filed 2026-02-25 | $6.76M 10-K · filed 2026-02-25 | ||||||
| 2024-09-30 | $2.96M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $5.75M derived: sum of 2 quarters · filed 2025-11-05 | $13.89M 10-Q · filed 2025-11-05 | $9.35M derived: sum of 4 quarters · filed 2026-02-25 | ||||||
| 2024-06-30 | $2.79M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | $10.94M 10-Q · filed 2025-08-06 | $6.39M derived: sum of 3 quarters · filed 2026-02-25 | $13.98M derived: sum of 4 quarters · filed 2026-02-25 | ||||||
| 2024-03-31 | $8.15M 10-Q · filed 2025-05-07 | $3.60M derived: sum of 2 quarters · filed 2026-02-25 | $11.19M derived: sum of 3 quarters · filed 2026-02-25 | $25.28M derived: sum of 4 quarters · filed 2026-02-25 | ||||||
| 2023-12-31 | -$4.55M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $3.04M derived: sum of 2 quarters · filed 2026-02-25 | $17.14M derived: sum of 3 quarters · filed 2026-02-25 | $28.48M 10-K · filed 2026-02-25 | ||||||
| 2023-09-30 | $7.58M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-31 | $21.68M derived: sum of 2 quarters · filed 2024-10-31 | $33.02M 10-Q · filed 2024-10-31 | $36.13M derived: sum of 4 quarters · filed 2025-02-25 | ||||||
| 2023-06-30 | $14.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-01 | $25.44M 10-Q · filed 2024-08-01 | $28.55M derived: sum of 3 quarters · filed 2025-02-25 | $34.66M derived: sum of 4 quarters · filed 2025-02-25 | ||||||
| 2023-03-31 | $11.34M 10-Q · filed 2024-05-03 | $14.45M derived: sum of 2 quarters · filed 2025-02-25 | $20.56M derived: sum of 3 quarters · filed 2025-02-25 | $27.38M derived: sum of 4 quarters · filed 2025-02-25 | ||||||
| 2022-12-31 | $3.11M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-25 | $9.22M derived: sum of 2 quarters · filed 2025-02-25 | $16.04M derived: sum of 3 quarters · filed 2025-02-25 | $25.68M 10-K · filed 2025-02-25 | ||||||
| 2022-09-30 | $6.11M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-01 | $12.93M derived: sum of 2 quarters · filed 2023-11-01 | $22.57M 10-Q · filed 2023-11-01 | $26.86M derived: sum of 4 quarters · filed 2024-02-29 | ||||||
| 2022-06-30 | $6.82M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-07-26 | $16.46M 10-Q · filed 2023-07-26 | $20.75M derived: sum of 3 quarters · filed 2024-02-29 | $15.87M derived: sum of 4 quarters · filed 2024-02-29 | ||||||
| 2022-03-31 | $9.64M 10-Q · filed 2023-05-03 | $13.93M derived: sum of 2 quarters · filed 2024-02-29 | $9.05M derived: sum of 3 quarters · filed 2024-02-29 | $3.53M derived: sum of 4 quarters · filed 2024-02-29 | ||||||
| 2021-12-31 | $4.29M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | -$587.00K derived: sum of 2 quarters · filed 2024-02-29 | -$6.11M derived: sum of 3 quarters · filed 2024-02-29 | -$4.48M 10-K · filed 2024-02-29 | ||||||
| 2021-09-30 | -$4.88M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-02 | -$10.40M derived: sum of 2 quarters · filed 2022-11-02 | -$8.78M 10-Q · filed 2022-11-02 | -$4.66M 10-Q · filed 2021-11-03 | -$26.36M derived: sum of 4 quarters · filed 2023-02-27 | |||||
| 2021-06-30 | -$5.52M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-03 | -$3.90M 10-Q · filed 2022-08-03 | -$1.22M 10-Q · filed 2021-07-28 | -$21.48M derived: sum of 3 quarters · filed 2023-02-27 | -$25.55M derived: sum of 4 quarters · filed 2023-02-27 | |||||
| 2021-03-31 | $1.63M 10-Q · filed 2022-05-04 | $2.90M 10-Q · filed 2021-04-28 | -$15.95M derived: sum of 2 quarters · filed 2023-02-27 | -$20.02M derived: sum of 3 quarters · filed 2023-02-27 | -$16.33M derived: sum of 4 quarters · filed 2023-02-27 | |||||
| 2020-12-31 | -$17.58M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-27 | -$21.65M derived: sum of 2 quarters · filed 2023-02-27 | -$17.95M derived: sum of 3 quarters · filed 2023-02-27 | -$5.44M 10-K · filed 2023-02-27 | -$1.40M 10-K · filed 2021-03-01 | |||||
| 2020-09-30 | -$4.07M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-03 | -$372.00K derived: sum of 2 quarters · filed 2021-11-03 | $12.14M 10-Q · filed 2021-11-03 | $1.88M derived: sum of 4 quarters · filed 2022-03-01 | ||||||
| 2020-06-30 | $3.70M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-28 | $16.21M 10-Q · filed 2021-07-28 | $5.95M derived: sum of 3 quarters · filed 2022-03-01 | $9.85M derived: sum of 4 quarters · filed 2022-03-01 | ||||||
| 2020-03-31 | $12.51M 10-Q · filed 2021-04-28 | $2.26M derived: sum of 2 quarters · filed 2022-03-01 | $6.15M derived: sum of 3 quarters · filed 2022-03-01 | $12.14M derived: sum of 4 quarters · filed 2022-03-01 | ||||||
| 2019-12-31 | -$10.26M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | -$6.36M derived: sum of 2 quarters · filed 2022-03-01 | -$368.00K derived: sum of 3 quarters · filed 2022-03-01 | $7.92M 10-K · filed 2022-03-01 | $10.61M 10-K · filed 2020-03-02 | |||||
| 2019-09-30 | $3.90M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-29 | $9.89M derived: sum of 2 quarters · filed 2020-10-29 | $18.18M 10-Q · filed 2020-10-29 | $21.21M derived: sum of 4 quarters · filed 2021-03-01 | ||||||
| 2019-06-30 | $5.99M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-29 | $14.28M 10-Q · filed 2020-07-29 | $17.31M derived: sum of 3 quarters · filed 2021-03-01 | $13.65M derived: sum of 4 quarters · filed 2021-03-01 | ||||||
| 2019-03-31 | $8.29M 10-Q · filed 2020-04-30 | $11.32M derived: sum of 2 quarters · filed 2021-03-01 | $7.65M derived: sum of 3 quarters · filed 2021-03-01 | $12.63M derived: sum of 4 quarters · filed 2021-03-01 | ||||||
| 2018-12-31 | $3.02M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | -$638.00K derived: sum of 2 quarters · filed 2021-03-01 | $4.34M derived: sum of 3 quarters · filed 2021-03-01 | $10.65M 10-K · filed 2021-03-01 | ||||||
| 2018-09-30 | -$3.66M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-30 | $1.32M derived: sum of 2 quarters · filed 2019-10-30 | $7.62M 10-Q · filed 2019-10-30 | -$10.57M derived: sum of 4 quarters · filed 2020-03-02 | ||||||
| 2018-06-30 | $4.98M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-31 | $11.29M 10-Q · filed 2019-07-31 | -$6.91M derived: sum of 3 quarters · filed 2020-03-02 | -$2.83M derived: sum of 4 quarters · filed 2020-03-02 | ||||||
| 2018-03-31 | $6.30M 10-Q · filed 2019-05-01 | -$11.89M derived: sum of 2 quarters · filed 2020-03-02 | -$7.81M derived: sum of 3 quarters · filed 2020-03-02 | -$5.32M derived: sum of 4 quarters · filed 2020-03-02 | ||||||
| 2017-12-31 | -$18.19M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-02 | -$14.11M derived: sum of 2 quarters · filed 2020-03-02 | -$11.62M derived: sum of 3 quarters · filed 2020-03-02 | -$7.19M 10-K · filed 2020-03-02 | ||||||
| 2017-09-30 | $4.08M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-01 | $6.57M derived: sum of 2 quarters · filed 2018-11-01 | $11.01M 10-Q · filed 2018-11-01 | $4.91M derived: sum of 4 quarters · filed 2019-03-18 | ||||||
| 2017-06-30 | $2.49M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-02 | $6.93M 10-Q · filed 2018-08-02 | $831.00K derived: sum of 3 quarters · filed 2019-03-18 | $4.96M derived: sum of 4 quarters · filed 2019-03-18 | ||||||
| 2017-03-31 | $4.44M 10-Q · filed 2018-05-03 | -$1.66M derived: sum of 2 quarters · filed 2019-03-18 | $2.47M derived: sum of 3 quarters · filed 2019-03-18 | -$11.47M derived: sum of 4 quarters · filed 2019-03-18 | ||||||
| 2016-12-31 | -$6.10M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-18 | -$1.97M derived: sum of 2 quarters · filed 2019-03-18 | -$15.90M derived: sum of 3 quarters · filed 2019-03-18 | -$26.70M 10-K · filed 2019-03-18 | ||||||
| 2016-09-30 | $4.13M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-02 | -$9.81M derived: sum of 2 quarters · filed 2017-11-02 | -$20.61M 10-Q · filed 2017-11-02 | |||||||
| 2016-06-30 | -$13.94M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09 | -$24.73M 10-Q · filed 2017-08-09 | ||||||||
| 2016-03-31 | -$10.80M 10-Q · filed 2017-05-03 | |||||||||
| 2015-12-31 | -$36.33M 10-K · filed 2017-03-01 | -$36.33M 10-K · filed 2018-02-28 | ||||||||
| 2015-10-18 | $1.05M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-02 | $1.76M 10-Q · filed 2015-12-08 | $4.85M 10-Q · filed 2016-11-02 | |||||||
| 2015-07-24 | $707.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-05 | $3.80M 10-Q · filed 2016-08-05 | ||||||||
| 2015-04-24 | $3.09M 10-Q · filed 2016-05-09 | $7.11M 10-K · filed 2018-02-28 | ||||||||
| 2014-10-24 | $1.70M 10-Q · filed 2015-12-08 | |||||||||
| 2014-04-25 | -$254.00K 10-K · filed 2017-03-01 | |||||||||
| 2013-04-26 | $3.40M 10-KT · filed 2016-03-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Integer Holdings Corp (ITGR) | United States | $4.289B | 25.17 |
| TransMedics Group, Inc. (TMDX) | United States | $2.911B | 15.17 |
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| BIOLIFE SOLUTIONS INC (BLFS) | United States | $1.887B | 23.80 |
| CONMED Corp (CNMD) | United States | $1.353B | 26.72 |
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |